rs61735984
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6BP7BS2
The NM_000155.4(GALT):c.510C>A(p.Ile170Ile) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00319 in 1,614,188 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000155.4 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALT | NM_000155.4 | c.510C>A | p.Ile170Ile | splice_region_variant, synonymous_variant | 6/11 | ENST00000378842.8 | NP_000146.2 | |
GALT | NM_001258332.2 | c.183C>A | p.Ile61Ile | splice_region_variant, synonymous_variant | 4/9 | NP_001245261.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALT | ENST00000378842.8 | c.510C>A | p.Ile170Ile | splice_region_variant, synonymous_variant | 6/11 | 1 | NM_000155.4 | ENSP00000368119.4 | ||
ENSG00000258728 | ENST00000556278.1 | c.255C>A | p.Ile85Ile | splice_region_variant, synonymous_variant | 3/8 | 5 | ENSP00000451792.1 |
Frequencies
GnomAD3 genomes AF: 0.00280 AC: 426AN: 152184Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00295 AC: 741AN: 251494Hom.: 4 AF XY: 0.00291 AC XY: 396AN XY: 135920
GnomAD4 exome AF: 0.00323 AC: 4725AN: 1461886Hom.: 12 Cov.: 33 AF XY: 0.00319 AC XY: 2317AN XY: 727244
GnomAD4 genome AF: 0.00280 AC: 426AN: 152302Hom.: 2 Cov.: 32 AF XY: 0.00298 AC XY: 222AN XY: 74460
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 12, 2017 | - - |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 29, 2020 | This variant is associated with the following publications: (PMID: 27176039, 11919338) - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | GALT: BP4, BP7, BS2 - |
Galactosemia Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | May 30, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at